HSPA5 and rheumatoid arthritis: These findings illustrate the importance of the balance between effector and regulatory T cells in disease pathogenesis, as well as the immunomodulatory potential of BiP [108], highlighting its potential as an immunotherapeutic agent in RA [100,106,107,110].